21.05.2024 02:52:05
|
Teva Says Simlandi Injection Now Available In U.S.
(RTTNews) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), and Alvotech (ALVO) announced the availability of Simlandi (adalimumab-ryvk) injection in the U.S., as an interchangeable biosimilar to Humira for the treatment of adult rheumatoid arthritis, juvenile idiopathic arthritis, adult psoriatic arthritis, adult ankylosing spondylitis, Crohn's disease, adult ulcerative colitis, adult plaque psoriasis, adult hidradenitis suppurativa and adult uveitis.
Simlandi is approved by the U.S. Food and Drug Administration as the first high-concentration, citrate-free biosimilar to Humira with interchangeability exclusivity for the 40mg/0.4mL injection.
Teva and Alvotech reached a strategic partnership for the exclusive commercialization of five of Alvotech's biosimilar product candidates in August 2020, and in July 2023, the collaboration was extended to include two additional biosimilars and new presentations of two previously partnered products.
For More Such Health News, visit rttnews.com.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)mehr Nachrichten
20.12.24 |
NASDAQ Composite Index-Papier Teva Pharmaceutical Industries-Aktie: So viel Gewinn hätte ein Investment in Teva Pharmaceutical Industries von vor einem Jahr abgeworfen (finanzen.at) | |
18.12.24 |
MÄRKTE USA/Etwas leichter - Teva haussieren dank Medikamentenstudie (Dow Jones) | |
17.12.24 |
NASDAQ-Handel NASDAQ Composite verliert schlussendlich (finanzen.at) | |
17.12.24 |
MÄRKTE USA/Etwas leichter - Teva haussieren dank Medikamentenstudie (Dow Jones) | |
17.12.24 |
Anleger in New York halten sich zurück: NASDAQ Composite zeigt sich am Dienstagnachmittag leichter (finanzen.at) | |
17.12.24 |
MÄRKTE USA/Etwas leichter - Medikamentenstudie beflügelt Teva (Dow Jones) | |
17.12.24 |
Schwacher Handel in New York: NASDAQ Composite mittags mit Abgaben (finanzen.at) | |
17.12.24 |
Börse New York in Rot: NASDAQ Composite zum Start leichter (finanzen.at) |
Analysen zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Alvotech Registered Shs | 11,25 | -2,17% | |
Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 21,40 | 2,39% |